推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

INTEGRATIVE CANCER THERAPIES

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 INTEGR CANCER T最新评论:请问大家awaiting reviewer selection状态大概需要等多久啊?投稿一个月了还没开始审稿 (2024-09-23)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
出版社推荐:
美国化学会ACS期刊一览
IF 2.9,JCR Q2 神经系统基础研究期刊征稿中
开放获取选刊时如何避雷?点击查看干货指南!
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


INTEGRATIVE CANCER THERAPIES期刊基本信息Hello,您是该期刊的第36245位访客

基本信息 登录收藏
期刊名字INTEGRATIVE CANCER THERAPIESINTEGRATIVE CANCER THERAPIES

INTEGR CANCER THER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.9
53人评分
我要评分

声誉
6.9

影响力
4.9

速度
7.0

期刊ISSN1534-7354
微信扫码收藏此期刊
E-ISSN1552-695X
2023-2024最新影响因子
(数据来源于搜索引擎)
2.9 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:2.039
2023-2024自引率3.40%点击查看自引率趋势图
五年影响因子3.4
JCI期刊引文指标 0.65
h-index 53
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
4.800.6870.757
学科分区排名百分位
大类:Medicine
小类:Complementary and Alternative Medicine
Q125 / 105
大类:Medicine
小类:Oncology
Q2178 / 404

期刊简介
ICT is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.
期刊官方网站https://us.sagepub.com/en-us/nam/integrative-cancer-therapies/journal201510
期刊投稿网址https://us.sagepub.com/en-us/nam/integrative-cancer-therapies/journal201510#submission-guidelines
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足INTEGRATIVE CANCER THERAPIES的语言要求,还能让INTEGRATIVE CANCER THERAPIES编辑和审稿人得到更好的审稿体验,让稿件最大限度地被INTEGRATIVE CANCER THERAPIES编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2650; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:health psychology、oncology、integrative care、cancer、alternative medicine、complementary medicine
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式SAGE PUBLICATIONS INC, 2455 TELLER RD, THOUSAND OAKS, USA, CA, 91320
出版商SAGE Publications Inc.
涉及的研究方向医学-全科医学与补充医学
出版国家或地区UNITED STATES
出版语言English
出版周期Quarterly
出版年份2002
年文章数 90点击查看年文章数趋势图
Gold OA文章占比92.25%
研究类文章占比:
文章 ÷(文章 + 综述)
80.00%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:INTEGRATIVE & COMPLEMENTARY MEDICINESCIEQ213/43
学科:ONCOLOGYSCIEQ2151/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:INTEGRATIVE & COMPLEMENTARY MEDICINESCIEQ219/43
学科:ONCOLOGYSCIEQ3164/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区3区3区
INTEGRATIVE & COMPLEMENTARY MEDICINE
全科医学与补充医学
4区3区3区
ONCOLOGY
肿瘤学
3区1区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区3区1区
INTEGRATIVE & COMPLEMENTARY MEDICINE
全科医学与补充医学
4区4区3区
ONCOLOGY
肿瘤学
4区1区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区3区2区
INTEGRATIVE & COMPLEMENTARY MEDICINE
全科医学与补充医学
1区1区3区
ONCOLOGY
肿瘤学
2区4区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1534-7354%5BISSN%5D
平均审稿速度网友分享经验:
>12周,或约稿
平均录用比例网友分享经验:
较易
版面费/APC文章处理费信息
文章处理费:需要( USD2650; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在INTEGRATIVE CANCER THERAPIES顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 INTEGRATIVE CANCER THERAPIES期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 INTEGRATIVE CANCER THERAPIES中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
INTEGRATIVE CANCER THERAPIES上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    AMERICAN JOURNAL OF CHINESE MEDICINE559.90
    JOURNAL OF ETHNOPHARMACOLOGY17010.30
    COMPLEMENTARY THERAPIES IN MEDICINE558.60
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE804.00
    Chinese Journal of Integrative Medicine285.90
    Explore-The Journal of Science and Healing33.00
    Homeopathy353.40
    ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH240.50
    African Journal of Traditional Complementary and Alternative Medicines00.00
    Alternative Medicine Review00.00
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE682716
    BIOMATERIALS570441
    BIOMEDICINE & PHARMACOTHERAPY556180
    Frontiers in Pharmacology519742
    Journal of Materials Chemistry B513798
    Frontiers in Immunology496997
    COMPUTERS IN BIOLOGY AND MEDICINE479587
    JOURNAL OF ETHNOPHARMACOLOGY470623
    COLLOIDS AND SURFACES B-BIOINTERFACES441005
    Frontiers in Oncology439734
  •  

    INTEGRATIVE CANCER THERAPIES INTEGRATIVE CANCER THERAPIES
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis.

    Author: Xie G1, Cui Z1, Peng K1, Zhou X1, Xia Q2,3, Xu D1,2,3.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418810799. doi: 10.1177/1534735418810799. Epub 2018 Nov 27.
        PubMed      DOI
    2.Shenqi Fuzheng Injection in the Treatment of Breast Cancer: A Meta-analysis of Randomized Controlled Trials.

    Author: Liu S1, Zhang D1, Wu J1, Wang K1, Zhao Y1, Ni M1, Meng Z1, Zhang X1.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418816824. doi: 10.1177/1534735418816824. Epub 2018 Dec 4.
        PubMed      DOI
    3.Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.

    Author: Liu Y1, May BH2, Zhang AL2, Guo X1, Lu C1, Xue CC1,2, Zhang H1.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418817833. doi: 10.1177/1534735418817833. Epub 2018 Dec 10.
        PubMed      DOI
    4.A Purified Resin Glycoside Fraction from Pharbitidis Semen Induces Paraptosis by Activating Chloride Intracellular Channel-1 in Human Colon Cancer Cells.

    Author: Zhu D1, Chen C1, Xia Y1, Kong LY1, Luo J1.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418822120. doi: 10.1177/1534735418822120. Epub 2019 Jan 7.
        PubMed      DOI
    5.Effects of Shen Cao Granules on Chemotherapy-Induced Thrombocytopenia in Gastrointestinal Cancer Patients: A Randomized Controlled Trial.

    Author: Yu C1, Liu W1, Mu Y1, Hou A1, Li Y1.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419829568. doi: 10.1177/1534735419829568.
        PubMed      DOI
    6.Combination of Astragali Polysaccharide and Curcumin Improves the Morphological Structure of Tumor Vessels and Induces Tumor Vascular Normalization to Inhibit the Growth of Hepatocellular Carcinoma.

    Author: Tang D1, Zhang S2, Shi X1, Wu J1, Yin G1, Tan X3, Liu F1, Wu X1, Du X1.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418824408. doi: 10.1177/1534735418824408.
        PubMed      DOI
    7.Meta-Analysis of 5-Fluorouracil-Based Chemotherapy Combined With Traditional Chinese Medicines for Colorectal Cancer Treatment.

    Author: Chen P1,2, Ni W2, Xie T1,2, Sui X2.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419828824. doi: 10.1177/1534735419828824.
        PubMed      DOI
    8.Network Meta-Analysis of Chinese Herbal Injections Plus the FOLFOX Regimen for the Treatment of Colorectal Cancer in China.

    Author: Zhang D1, Wu J1, Duan X1, Wang K1, Ni M1, Liu S1, Zhang X1, Zhang B1, Zhao Y1.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419827098. doi: 10.1177/1534735419827098.
        PubMed      DOI
    9.The Efficacy of Cognitive Behavioral Therapy to Treat Depression and Anxiety and Improve Quality of Life Among Early-Stage Breast Cancer Patients.

    Author: Sun H1, Huang H2, Ji S1, Chen X1, Xu Y2, Zhu F3, Wu J1.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419829573. doi: 10.1177/1534735419829573.
        PubMed      DOI
    10.Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study.

    Author: Li CL1, Hsia TC2,3,4,5, Li CH2,3,4, Chen KJ5, Yang YH5,6,7, Yang ST8,9.
    Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419827079. doi: 10.1177/1534735419827079.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Computational Visual Media016.90
    Industrial and Organizational Psychology-Perspectives on Science and Practice07.70
    COMMUNICATIONS OF THE ACM18916.10
    MedComm06.70
    Journal of Econometrics1358.60
    CLINICAL NUCLEAR MEDICINE532.90
    Journal of International Financial Management & Accounting09.10
    BMJ Evidence-Based Medicine08.90
    ARCHIVOS DE BRONCONEUMOLOGIA413.50
    ARCHIVOS DE BRONCONEUMOLOGIA463.50
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共82


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室